Format

Send to

Choose Destination
See comment in PubMed Commons below
Immunol Today. 1999 Mar;20(3):130-4.

Tissue transglutaminase: apoptosis versus autoimmunity.

Author information

1
Dept of Biology, University of Rome Tor Vergata, Italy. mauro.piacentini@UniRoma2.it

Abstract

Autoimmune diseases are characterized by multiple autoantibodies and/or autoreactive T cells that recognize a large number of antigens. Many of these antigens undergo extensive post-translational modifications during apoptosis and act as substrates for the proapoptotic cystein proteases. Here, Mauro Piacentini and Vittorio Colizzi discuss the effects on autoimmunity produced by post-translational modifications of proteins catalysed by the proapoptotic enzyme tissue transglutaminase.

PMID:
10203704
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center